TriCell Biologics is a versatile medical device company and a pioneer in bringing life-changing regenerative tools and technologies to the field of Orthopedics, Spine, Trauma, Cosmetology, Sports Medicine, Podiatry, and Vascular/Plastic Surgery. Founded in 2017 and headquartered in India, the company has established continued growth and demand for its products throughout the region. TriCell Biologics remains committed to providing affordable healthcare technologies to create an impact on the lives they touch every day. With a clear focus on innovation and addressing unmet medical needs, the company presents an exciting investment opportunity in the rapidly growing regenerative medicine market. Although details about the last investment and associated investors are currently unavailable, TriCell Biologics' dedication to bringing advanced medical solutions to the market positions it as an intriguing prospect for potential investors seeking exposure to the healthcare and biotechnology industries.
There is no investment information
No recent news or press coverage available for TriCell Biologics.